In accordance with the Food and Drug Administration's change order for drug manufacturing (import) items (Permit Review and Coordination Division No. 3074, effective date 2011.9.8), the efficacy, dosage, and precautions for use of Inhipla and Inhipla tablets have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.